SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
07/16/2025
Back to search
Official data from USPTO
MAYNE PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
36
Latest update
07/22/2025
Trademark type
Combined
Nice classes
5, 10
Filing date
01/25/2024
Registration date
07/01/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/01/2025
Last transaction
07/22/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
04/27/2018
First use in commerce
04/27/2018
Drawing code
3
Owner type
03
Owner location
SALISBURY SOUTH SA, AU
Examiner
SIRIGNANO, EMMA
Law office
M40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "MAYNE PHARMA" and a circle design. The wording "MAYNE" is within a shaded circle. The wording "PHARMA" is to the right of the circle.
Holders and representatives
Holders
Mayne Pharma International Pty Ltd
Representatives
Melissa A. Nowak Christensen O'Connor Johnson Kindness
Technical classification
Nice Classes
Class 5Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations in the field of gynecology and women's healthcontraceptive preparations and oral contraceptives; hormone replacement therapy preparations containing estradiol and progesterone for use in treating the symptoms associated with menopause; pharmaceutical preparations for the treatment of vulval vaginal atrophy; antibiotic preparations; pharmaceutical preparations for the treatment of dermatological diseases and disorders; topical foam pharmaceutical preparations for treatment of steroid responsive dermatoses; pharmaceutical preparations for the treatment of rosacea and erythema associated with rosacea; pharmaceutical preparations for the treatment of psoriasis; antifungal preparations; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical substances and preparations for the treatment of cancer; dietary and nutritional supplements; vitamins
Class 10
contraceptive apparatus in the field of gynecology and women's health
Publications
History of USPTO decisions and trademark events.
36 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/01/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
07/01/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/11/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/15/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/15/2025
EISU
TEAS STATEMENT OF USE RECEIVED
02/26/2025
IUAF
USE AMENDMENT FILED
02/25/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/11/2025
CHPB
POST PUBLICATION AMENDMENT - ENTERED
01/24/2025
APET
ASSIGNED TO PETITION STAFF
01/21/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/17/2024
PUBO
PUBLISHED FOR OPPOSITION
12/17/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/11/2024
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
12/03/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/19/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
11/19/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/19/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
11/19/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/19/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/29/2024
GNRT
NON-FINAL ACTION E-MAILED
10/29/2024
CNRT
NON-FINAL ACTION WRITTEN
10/29/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
10/24/2024
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
09/24/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/07/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/21/2024
GNRT
NON-FINAL ACTION E-MAILED
08/21/2024
CNRT
NON-FINAL ACTION WRITTEN
08/21/2024
DOCK
ASSIGNED TO EXAMINER
08/21/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
08/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
08/01/2024
NWAP
NEW APPLICATION ENTERED
01/25/2024
Continuous trademark protection
Get notified about every new filing that threatens MAYNE PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.